Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV000408447 | SCV000281886 | likely pathogenic | Severe early-childhood-onset retinal dystrophy | 2016-01-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000779005 | SCV000915446 | pathogenic | ABCA4-related disorder | 2019-01-12 | criteria provided, single submitter | clinical testing | Across a selection of the literature, the ABCA4 c.4328G>A (p.Arg1443His) missense variant has been reported in a compound heterozygous state in at least five individuals, including four affected with Stargardt disease, one described as affected with ABCA4-associated disease and one with ABCA4-associated retinopathies (Rivera et al. 2000; Testa et al. 2012; Chacón-Camacho et al. 2013; Fujinami et al. 2013; Nõupuu et al. 2014; Schulz et al. 2017). In addition Roberts et al. (2011) identified the p.Arg1443His variant in one patient allele from a cohort of 181 individuals with ABCA4-associated retinopathies. The variant was absent from 220 control individuals and is reported at a frequency of 0.000045 in the European (non-Finnish) population of the Exome Aggregation Consortium. The Arg1443 residue is noted to be well conserved. Biswas-Fiss et al. (2010) compared the ABCA4 wild type structure with that of three variant structures, including the p.Arg1443His variant using CD spectral analysis. The p.Arg1443His variant structure was shown to be significantly altered with loss of alpha-helical secondary structure. The same study also demonstrated decreased binding affinity to its substrate. Based on the collective evidence, the p.Arg1443His variant is classified as pathogenic for ABCA4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Blueprint Genetics | RCV001073587 | SCV001239138 | pathogenic | Retinal dystrophy | 2019-07-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000085631 | SCV001418752 | pathogenic | not provided | 2025-01-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1443 of the ABCA4 protein (p.Arg1443His). This variant is present in population databases (rs61750142, gnomAD 0.004%). This missense change has been observed in individual(s) with autosomal recessive Stargardt disease (PMID: 15161829, 22661472, 23419329, 23982839, 28118664, 29925512). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99278). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCA4 function (PMID: 20404325). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Molecular Genetics, |
RCV000408447 | SCV001548105 | likely pathogenic | Severe early-childhood-onset retinal dystrophy | 2021-01-30 | criteria provided, single submitter | clinical testing | |
3billion, |
RCV000408447 | SCV002058940 | pathogenic | Severe early-childhood-onset retinal dystrophy | 2022-01-03 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000099278, PS1_S). The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported (PM1_M). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000021, PM2_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.805, 3CNET: 0.958, PP3_P). A missense variant is a common mechanism associated with Stargardt disease 1 (PP2_P). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Mendelics | RCV002247490 | SCV002517484 | pathogenic | Age related macular degeneration 2 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Ophthalmic Genetics Group, |
RCV003324511 | SCV004030420 | pathogenic | Stargardt disease | 2023-07-24 | criteria provided, single submitter | research | Clinical significance based on ACMG v2.0 |
Dept Of Ophthalmology, |
RCV001073587 | SCV004707412 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV001073587 | SCV005071059 | likely pathogenic | Retinal dystrophy | 2021-01-01 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV001073587 | SCV005420733 | pathogenic | Retinal dystrophy | 2024-10-04 | criteria provided, single submitter | research | PS3,PM5,PM2,PP3,PM3(strong) |
Fulgent Genetics, |
RCV005025157 | SCV005657303 | pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-04-03 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085631 | SCV000117770 | not provided | not provided | no assertion provided | not provided | ||
Prevention |
RCV000779005 | SCV004106330 | likely pathogenic | ABCA4-related disorder | 2024-09-06 | no assertion criteria provided | clinical testing | The ABCA4 c.4328G>A variant is predicted to result in the amino acid substitution p.Arg1443His. This variant was reported in the compound heterozygous state in several individuals with autosomal recessive ABCA4-related disorders (Rivera et al 2000. PubMed ID: 10958763; Fujinami K et al 2018. PubMed ID: 29925512; Salles MV et al 2018. PubMed ID: 30093795; Fujinami K et al 2013. PubMed ID: 23982839; Testa F et al 2012. PubMed ID: 22661472; Nõupuu K et al 2014. PubMed ID: 25301883; Lin et al. 2024. PubMed ID: 38219857). This variant is reported in 0.0039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. |
Ophthalmo- |
RCV000408447 | SCV005047014 | pathogenic | Severe early-childhood-onset retinal dystrophy | no assertion criteria provided | research |